Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain · Delayed Price · Currency is EUR 59.00
+0.05 (0.08%)
May 18, 2026, 4:33 PM CET
BME:ROVI Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 131.82 | 140.44 | 136.88 | 170.34 | 199.67 | 153.08 |
Depreciation & Amortization | 29.64 | 28.76 | 26.92 | 23.44 | 21.84 | 20.3 |
Other Amortization | 1.62 | 1.62 | 1.09 | 0.9 | 1.03 | 1.06 |
Loss (Gain) From Sale of Assets | 1.78 | 0.01 | 4.39 | - | - | - |
Loss (Gain) From Sale of Investments | 0.44 | 0.51 | -0.08 | 0.22 | -1.83 | -1.16 |
Loss (Gain) on Equity Investments | -0.18 | -0.06 | 0.14 | 0.13 | -0.2 | -0.18 |
Stock-Based Compensation | - | - | - | - | - | 1.4 |
Provision & Write-off of Bad Debts | -0.31 | -0.31 | -7.97 | -0.04 | 0.04 | -0.27 |
Other Operating Activities | 20.94 | 11.55 | -32.06 | -47.28 | 74.03 | 39.24 |
Change in Accounts Receivable | -32.45 | -30.19 | 13.41 | 19.47 | -26.82 | -74.19 |
Change in Inventory | 44.03 | 42.99 | 11.87 | -29.29 | -71.59 | -23.43 |
Change in Accounts Payable | -15.52 | -7.75 | -16.36 | -23.92 | 41.67 | 35.36 |
Change in Other Net Operating Assets | -0.63 | -0.5 | 0.04 | -0.7 | -0.23 | -1.78 |
Operating Cash Flow | 181.19 | 187.08 | 138.28 | 113.25 | 237.6 | 149.44 |
Operating Cash Flow Growth | 27.98% | 35.29% | 22.10% | -52.34% | 58.99% | 218.80% |
Capital Expenditures | -64.65 | -65.21 | -59.12 | -53.79 | -50.72 | -40.22 |
Sale of Property, Plant & Equipment | 0.14 | 0.14 | 0.04 | 0.38 | 0.08 | 0.03 |
Sale (Purchase) of Intangibles | -2.58 | -2.6 | -3.1 | -1.39 | -0.67 | -0.72 |
Investment in Securities | - | -3.46 | -19.01 | 1.29 | -5.85 | - |
Other Investing Activities | 0.98 | 2.66 | 0.13 | 1.49 | 0.01 | 0.07 |
Investing Cash Flow | -66.11 | -68.48 | -81.06 | -52.03 | -57.15 | -40.84 |
Long-Term Debt Issued | - | 47.61 | 96.95 | 0.73 | 1.4 | 1.34 |
Long-Term Debt Repaid | - | -46.79 | -51.71 | -13.65 | -6.77 | -6.19 |
Net Debt Issued (Repaid) | -0.31 | 0.82 | 45.24 | -12.92 | -5.37 | -4.85 |
Issuance of Common Stock | 61.91 | 54.85 | 41.92 | 52.64 | 77.77 | 42.33 |
Repurchase of Common Stock | -61.69 | -54.86 | -89.71 | -133.9 | -177.01 | -78.79 |
Common Dividends Paid | -47.83 | -47.83 | -56.45 | -69.05 | -51.01 | -21.13 |
Other Financing Activities | 0.92 | -0.79 | 3.64 | 2.39 | 1.08 | -0.29 |
Financing Cash Flow | -47 | -47.81 | -55.36 | -160.84 | -154.54 | -62.73 |
Net Cash Flow | 68.09 | 70.79 | 1.86 | -99.62 | 25.91 | 45.87 |
Free Cash Flow | 116.54 | 121.87 | 79.16 | 59.45 | 186.88 | 109.22 |
Free Cash Flow Growth | 39.98% | 53.95% | 33.15% | -68.19% | 71.10% | 1348.77% |
Free Cash Flow Margin | 15.73% | 16.39% | 10.37% | 7.17% | 22.86% | 16.84% |
Free Cash Flow Per Share | 2.28 | 2.38 | 1.55 | 1.12 | 3.50 | 1.97 |
Cash Interest Paid | 2.3 | 2.3 | 1.77 | 0.39 | 0.29 | 0.29 |
Cash Income Tax Paid | 41.93 | 41.93 | 44.23 | 40.86 | 43.89 | 23.86 |
Levered Free Cash Flow | 75.69 | 82.3 | 44.85 | 25.36 | 135.92 | 66.2 |
Unlevered Free Cash Flow | 77.39 | 83.9 | 46.09 | 25.95 | 136.45 | 66.76 |
Change in Working Capital | -4.57 | 4.55 | 8.96 | -34.45 | -56.97 | -64.03 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.